DJIA 16,912.11 -70.48 -0.42%
NASDAQ 4,442.70 -2.21 -0.05%
S&P 500 1,969.95 -8.96 -0.45%
market minute promo

14.11 0.11 (0.79%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VNDA $14.11 0.79%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $14.04
Previous Close $14.00
Daily Range $13.81 - $14.34
52-Week Range $5.70 - $19.25
Market Cap $478.0M
P/E Ratio -10.77
Dividend (Yield) $0.00 (0.0%)
Volume 432,926
Average Daily Volume 535,254
Current FY EPS -$2.39

Sector

Healthcare

Industry

Drugs

Vanda Pharmaceuticals, Inc. (VNDA) Description

A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders. Website: http://www.vandapharmaceuticals.com/

News & Commentary Rss Feed

Vanda Pharmaceuticals' Q4 Loss Widens on Higher Expenses

Vanda Pharmaceuticals reduced R&D expenses by 41%, but a tripling in SG&A expenses combined with modest Fanapt growth caused its loss to widen by 20%.

3 Small-Cap Biotechs That Institutions Are Loving

Biotech Stock Mailbag: Vanda, Navidea, Provectus

Trade-Ideas: Vanda Pharmaceuticals (VNDA) Is Today's "Perilous Reversal" Stock

Vanda Up on EU News - Analyst Blog

Vanda Shares Jumped 29% Amid Continued Success Of Hetlioz

Wednesday's ETF Movers: XBI, GXC

Healthcare Stocks Mixed; Vanda Pharmaceutical Adds More Than 25% After 'Non-24' Medication Wins Orph

Healthcare Stocks Mixed; Vanda Pharmaceutical Adds More Than 25% After 'Non-24' Medication Wins Orphan Drug Status in Europe

Why Vanda Pharmaceuticals (VNDA) Stock Is Surging Today

Benzinga's Volume Movers

John Paulson's Stocks Trading for Less Than He Paid for Them

See More VNDA News...

VNDA's Top Competitors

VNDA $14.11 (0.79%)
Current stock: VNDA
AMGN $123.31 (0.54%)
Current stock: AMGN
GILD $92.99 (1.67%)
Current stock: GILD
BIIB $341.73 (1.59%)
Current stock: BIIB